Erikssen Gunnar, Aboulhosn Jamil, Lin Jeannette, Liestøl Knut, Estensen Mette E, Gjesdal Ola, Skulstad Helge, Døhlen Gaute, Lindberg Harald Lauritz
ACHD Unit, Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Ahmanson/UCLA Adult Congenital Heart Disease Center, UCLA Medical Plaza, Los Angeles, California, USA.
Open Heart. 2018 Oct 18;5(2):e000902. doi: 10.1136/openhrt-2018-000902. eCollection 2018.
Patients with univentricular hearts (UVH) have high mortality despite modern treatment, and better methods to identify patients at highest risk are needed. We wanted to improve risk stratification in patients with UVH by focusing on the prognostic significance of single right versus single left ventricular morphology (SRV vs SLV).
All 395 patients with UVH operated at our centre were prospectively included from 1972 to 2016 (195 SRV, 166 SLV, 34 mixed or indeterminate ventricular morphology). Diagnoses, UVH morphology, types of all operations and time and causes of death or heart transplantation (HTX) were recorded. The primary endpoint was death or HTX.
Among the 111 non-Fontan patients, 88 died (SRV 62 vs SLV 20; p<0.0001), 32 due to heart failure (SRV 23 vs SLV 5; p=0.0012). Twenty-five years of cumulative SRV versus SLV survival among the 284 Fontan patients (41 deaths/HTX) was 66.9% vs 87.9% (p=0.0027), partly explained by more deaths/HTX due to heart failure among patients with SRV (p=0.0006). Survival in patients with SRV with and without hypoplastic left heart syndrome (HLHS) was similar. SRV versus SLV was a strong predictor of death/HTX in multivariable proportional hazards analyses (RR 3.3, 95% CI 1.6 to 6.6).
SRV versus SLV is a strong short-term and long-term predictor of survival among patients with UVH, mainly explained by higher rates of death/HTX due to heart failure in the SRV group. Our findings apply to patients with SRV both with and without HLHS.
尽管有现代治疗手段,单心室心脏(UVH)患者的死亡率仍然很高,因此需要更好的方法来识别高危患者。我们希望通过关注单右心室与单左心室形态(SRV与SLV)的预后意义,来改善UVH患者的风险分层。
1972年至2016年期间,前瞻性纳入了在我们中心接受手术的所有395例UVH患者(195例SRV,166例SLV,34例混合或不确定心室形态)。记录诊断、UVH形态、所有手术类型以及死亡或心脏移植(HTX)的时间和原因。主要终点是死亡或HTX。
在111例非Fontan手术患者中,88例死亡(SRV组62例,SLV组20例;p<0.0001),其中32例死于心力衰竭(SRV组23例,SLV组5例;p=0.0012)。284例Fontan手术患者中,SRV组与SLV组25年累积生存率分别为66.9%和87.9%(p=0.0027),部分原因是SRV组因心力衰竭导致的死亡/HTX更多(p=0.0006)。有无左心发育不全综合征(HLHS)的SRV患者生存率相似。在多变量比例风险分析中,SRV与SLV是死亡/HTX的有力预测因素(风险比3.3,95%置信区间1.6至6.6)。
SRV与SLV是UVH患者生存的强有力短期和长期预测因素,主要原因是SRV组因心力衰竭导致的死亡/HTX发生率更高。我们的研究结果适用于有或无HLHS的SRV患者。